287 related articles for article (PubMed ID: 31889756)
1. Ablative Therapy for Unresectable Intrahepatic Cholangiocarcinoma: A Systematic Review and Meta-Analysis.
Yousaf A; Kim JU; Eliahoo J; Taylor-Robinson SD; Khan SA
J Clin Exp Hepatol; 2019; 9(6):740-748. PubMed ID: 31889756
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis.
Clements O; Eliahoo J; Kim JU; Taylor-Robinson SD; Khan SA
J Hepatol; 2020 Jan; 72(1):95-103. PubMed ID: 31536748
[TBL] [Abstract][Full Text] [Related]
3. Cholangiocarcinoma miscoding in hepatobiliary centres.
Selvadurai S; Mann K; Mithra S; Bridgewater J; Malik H; Khan SA
Eur J Surg Oncol; 2021 Mar; 47(3 Pt B):635-639. PubMed ID: 33032867
[TBL] [Abstract][Full Text] [Related]
4. The prognostic role of lymphovascular invasion and lymph node metastasis in perihilar and intrahepatic cholangiocarcinoma.
Lurje G; Bednarsch J; Czigany Z; Lurje I; Schlebusch IK; Boecker J; Meister FA; Tacke F; Roderburg C; Den Dulk M; Gaisa NT; Bruners P; Neumann UP
Eur J Surg Oncol; 2019 Aug; 45(8):1468-1478. PubMed ID: 31053477
[TBL] [Abstract][Full Text] [Related]
5. Liver Transplantation for Intrahepatic Cholangiocarcinoma: Ready for Prime Time?
Sapisochin G; Ivanics T; Heimbach J
Hepatology; 2022 Feb; 75(2):455-472. PubMed ID: 34859465
[TBL] [Abstract][Full Text] [Related]
6. Specific prognostic factors in hepatitis B virus-related and non-hepatitis B virus-related intrahepatic cholangiocarcinoma after macroscopic curative resection.
Huang J; Wang X; Zhu Y; Wang Z; Li J; Xu D; Wang S; Li TE; Lu L
J Surg Oncol; 2019 Jan; 119(1):40-46. PubMed ID: 30480811
[TBL] [Abstract][Full Text] [Related]
7. [Local and locoregional treatment of intrahepatic cholangiocarcinoma].
Wacker F; Dewald C
Radiologe; 2022 Mar; 62(3):247-252. PubMed ID: 34981129
[TBL] [Abstract][Full Text] [Related]
8. The prognostic impact of preoperative body composition in perihilar and intrahepatic cholangiocarcinoma.
Lurje I; Czigany Z; Eischet S; Bednarsch J; Ulmer TF; Isfort P; Strnad P; Trautwein C; Tacke F; Neumann UP; Lurje G
Hepatol Commun; 2022 Sep; 6(9):2400-2417. PubMed ID: 35616275
[TBL] [Abstract][Full Text] [Related]
9. Liver Transplantation for Intrahepatic Cholangiocarcinoma: A Meta-analysis and Meta-regression of Survival Rates.
Ziogas IA; Giannis D; Economopoulos KP; Hayat MH; Montenovo MI; Matsuoka LK; Alexopoulos SP
Transplantation; 2021 Oct; 105(10):2263-2271. PubMed ID: 33196623
[TBL] [Abstract][Full Text] [Related]
10. Non-alcoholic fatty liver disease as a risk factor for cholangiocarcinoma: a systematic review and meta-analysis.
Wongjarupong N; Assavapongpaiboon B; Susantitaphong P; Cheungpasitporn W; Treeprasertsuk S; Rerknimitr R; Chaiteerakij R
BMC Gastroenterol; 2017 Dec; 17(1):149. PubMed ID: 29216833
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of systemic induction therapy in initially unresectable locally advanced intrahepatic and perihilar cholangiocarcinoma: A systematic review.
Belkouz A; Nooijen LE; Riady H; Franken LC; van Oijen MGH; Punt CJA; Erdmann JI; Klümpen HJ
Cancer Treat Rev; 2020 Dec; 91():102110. PubMed ID: 33075684
[TBL] [Abstract][Full Text] [Related]
12. Role of Percutaneous Ablation in the Management of Intrahepatic Cholangiocarcinoma.
Charalampopoulos G; Iezzi R; Tsitskari M; Mazioti A; Papakonstantinou O; Kelekis A; Kelekis N; Filippiadis D
Medicina (Kaunas); 2023 Jun; 59(7):. PubMed ID: 37511998
[TBL] [Abstract][Full Text] [Related]
13. Hepatic Arterial Infusion Pump Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma: A Systematic Review and Meta-Analysis.
Holster JJ; El Hassnaoui M; Franssen S; IJzermans JNM; de Jonge J; Mostert B; Polak WG; de Wilde RF; Homs MYV; Groot Koerkamp B
Ann Surg Oncol; 2022 Sep; 29(9):5528-5538. PubMed ID: 35294656
[TBL] [Abstract][Full Text] [Related]
14. Microwave ablation versus liver resection for primary intrahepatic cholangiocarcinoma within Milan criteria: a long-term multicenter cohort study.
Pang C; Li J; Dou J; Li Z; Li L; Li K; Chen Q; An C; Zhou Z; He G; Lou K; Liang F; Xi H; Wang X; Zuo M; Cheng Z; Han Z; Liu F; Yu X; Yu J; Jiang X; Yang M; Liang P
EClinicalMedicine; 2024 Jan; 67():102336. PubMed ID: 38261915
[TBL] [Abstract][Full Text] [Related]
15. Comparing the clinicopathological characteristics of combined hepatocellular-cholangiocarcinoma with those of other primary liver cancers by use of the updated World Health Organization classification.
Yen CC; Yen CJ; Shan YS; Lin YJ; Liu IT; Huang HY; Yeh MM; Chan SH; Tsai HW
Histopathology; 2021 Oct; 79(4):556-572. PubMed ID: 33837585
[TBL] [Abstract][Full Text] [Related]
16. Any role for transarterial radioembolization in unresectable intrahepatic cholangiocarcinoma in the era of advanced systemic therapies?
Elvevi A; Laffusa A; Elisei F; Morzenti S; Guerra L; Rovere A; Invernizzi P; Massironi S
World J Hepatol; 2023 Dec; 15(12):1284-1293. PubMed ID: 38223418
[TBL] [Abstract][Full Text] [Related]
17. Differences in immunohistochemical biomarkers between intra- and extrahepatic cholangiocarcinoma: a systematic review and meta-analysis.
Wiggers JK; Ruys AT; Groot Koerkamp B; Beuers U; ten Kate FJ; van Gulik TM
J Gastroenterol Hepatol; 2014 Aug; 29(8):1582-94. PubMed ID: 24787096
[TBL] [Abstract][Full Text] [Related]
18. Cholangiocarcinoma: The Current Status of Surgical Options including Liver Transplantation.
Esmail A; Badheeb M; Alnahar B; Almiqlash B; Sakr Y; Khasawneh B; Al-Najjar E; Al-Rawi H; Abudayyeh A; Rayyan Y; Abdelrahim M
Cancers (Basel); 2024 May; 16(11):. PubMed ID: 38893067
[TBL] [Abstract][Full Text] [Related]
19. Narrative review: current management and novel targeted therapies in intrahepatic cholangiocarcinoma.
Bath NM; Pawlik TM
Chin Clin Oncol; 2023 Feb; 12(1):5. PubMed ID: 36922354
[TBL] [Abstract][Full Text] [Related]
20. The Role of Conventional and Stereotactic Microwave Ablation for Intrahepatic Cholangiocarcinoma.
Kim-Fuchs C; Candinas D; Lachenmayer A
J Clin Med; 2021 Jul; 10(13):. PubMed ID: 34279447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
